Comments
Loading...
Quince Therapeutics (NASDAQ:QNCX) Stock, Earnings Estimates, EPS, And Revenue
Quince Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$-0.130
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Quince Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Quince Therapeutics (QNCX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2022 | 2022-11-09 | $-0.22 | $-0.29 | 24.1 % |
| Jun 2022 | 2022-08-09 | $-0.51 | $-0.48 | -6.25 % |
| Mar 2022 | 2022-05-10 | $-0.72 | $-0.55 | -30.9 % |
| Dec 2021 | 2022-03-01 | $-0.78 | $-0.65 | -20.0 % |
Quince Therapeutics (QNCX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Quince Therapeutics (NASDAQ:QNCX) reporting earnings?
Quince Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.
What were the latest earnings per share (EPS) for Quince Therapeutics (NASDAQ:QNCX)?
Quince Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-0.13, which missed the estimate of $0.00.
What were Quince Therapeutics’s (NASDAQ:QNCX) revenues?
Quince Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.